Insiders Soleno Therapeutics, Inc.

Equities

SLNO

US8342033094

Market Closed - Nasdaq Other stock markets 01:30:00 21/05/2024 am IST			5-day change	1st Jan Change
47.01 ^USD	+1.84%		+9.84%	+16.80%

13/05	Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating	MT
10/05	Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Soleno Therapeutics, Inc. Announces Gwen Melincoff, Intends Not Intend to Stand for Re-Election as Director	23/04	CI
Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing	04/04	MT
Soleno Therapeutics Names Meredith Manning as Chief Commercial Officer	24/01	MT
Soleno Therapeutics Strengthens Leadership Team with Key Appointments	24/01	CI
Soleno Therapeutics Insider Sold Shares Worth $1,412,431, According to a Recent SEC Filing	15/12	MT
Soleno Therapeutics Insider Sold Shares Worth $1,182,828, According to a Recent SEC Filing	14/12	MT
Soleno Therapeutics Insider Sold Shares Worth $222,177, According to a Recent SEC Filing	01/12	MT
Soleno Therapeutics Insider Sold Shares Worth $1,471,049, According to a Recent SEC Filing	01/12	MT
Soleno Therapeutics Appoints Matthew Pauls to Board of Directors	16/23/16	CI
Insider Buy: Soleno Therapeutics	02/23/02	MT
Insider Sell: Soleno Therapeutics	16/23/16	MT
Insider Trends: Soleno Therapeutics Insider Continues 90-Day Selling Trend	04/21/04	MT
Soleno Therapeutics, Inc. Announces Executive Changes	21/20/21	CI
Soleno Therapeutics, Inc. Announces Executive Changes	16/19/16	CI
Soleno Therapeutics Appoints Birgitte Volck to its Board of Directors	12/19/12	CI
Soleno Therapeutics, Inc. Announces Management Changes	29/19/29	CI
Soleno Therapeutics, Inc. Announces Appointment of Andrew Sinclair in Board of Directors	18/19/18	CI
Soleno Therapeutics, Inc Announces Board Changes	20/18/20	CI
Soleno Therapeutics, Inc. Announces Board and Committee Changes	22/18/22	CI
Soleno Therapeutics, Inc. Appoints Jonathan Wolter as Chief Financial Officer on Non-Interim Basis	04/18/04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Soleno Therapeutics, Inc.

Equities

SLNO

US8342033094

Insiders

Filters